DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Hillery CA, Mancuso DJ, Evan Sadler J. et al.
Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Blood 1998;
91 (05) 1572-1581
We do not assume any responsibility for the contents of the web pages of other providers.